The promise of widespread enterprise AI is held back by a fundamental problem: many companies still run on legacy, on-premise systems from the 80s and 90s. This "digital transformation" bottleneck must be solved first, as AI can't be adopted until the prerequisite move to modern cloud infrastructure is complete.

AI coding's true enterprise value is limited because models struggle with legacy systems. Companies run on trillions of lines of mediocre code in old languages like COBOL—a problem that requires human intervention over decades, not a simple AI solution, which limits immediate, real-world impact.

Contrary to expectations, IBM's mainframe business is growing because moving its critical workloads (like banking transactions) to the cloud would be three times more expensive. Mainframes provide unparalleled availability and processing power for specific batch workloads, creating a strong economic moat.

A primary barrier to modernizing healthcare is that its core technology, the Electronic Health Record (EHR), is often built on archaic foundations from the 1960s-80s. This makes building modern user experiences incredibly difficult.

Youngkin pinpoints two culprits for chronic government IT failures: a belief that everything requires a massive, inflexible enterprise system, and an internal talent base unprepared for modern tech. This leads to budget overruns, project delays, and vendor mismanagement.

While modern UIs are essential, the backend IBM i (AS/400) platform remains entrenched in many businesses. The reason is its extreme reliability and stability, which would require massive, difficult, and expensive custom software development to achieve on open systems like Linux.

The primary reason multi-million dollar AI initiatives stall or fail is not the sophistication of the models, but the underlying data layer. Traditional data infrastructure creates delays in moving and duplicating information, preventing the real-time, comprehensive data access required for AI to deliver business value. The focus on algorithms misses this foundational roadblock.

Large enterprises operate on complex webs of legacy systems, compliance controls, and fragile integrations. Their high risk aversion and lengthy change management cycles create a powerful inertia that will significantly delay the replacement of established B2B software, regardless of how capable AI agents become. Enterprise architecture moves slower than market hype.

Using disconnected financial systems for modern, complex trials technically works but leads to crashes, slowness, and constant troubleshooting. This unsustainability directly risks study performance, site success, and patient engagement, making modernization a necessity, not a choice.